← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2008Last known activity
Aug 13, 2024
Timeline
1950s
- Jun 1, 1959
Wonju Christian Hospital— Founded
Drugs by trial phase (44 distinct, 31 trials)
Phase 4 (19 own, 0 via acquisition)
Phase 3 (15 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Ascites
- Asthma
- Coronary Artery Disease
- Crohn Disease
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Neuropathies
- Encephalitis
- Encephalitis, Japanese
- Essential Hypertension
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Hypertension
- Influenza, Human
- Lung Diseases
- Lung Diseases, Obstructive
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Neuralgia
- Pancreatic Neoplasms
- Prostatic Neoplasms
- Pulmonary Disease, Chronic Obstructive
Recent trials (35)
- NCT07017088Sponsor investigatorN/AAug 13, 2024
- NCT07017088Lead sponsorN/AAug 13, 2024
- NCT05874674Lead sponsorN/ADec 1, 2023
- NCT05845489CollaboratorPhase 4Mar 9, 2023
- NCT05770674CollaboratorN/AApr 1, 2022
- NCT05194592Reponsible party - principal investigatorPhase 4Jan 7, 2022
- NCT05194592Lead sponsorPhase 4Jan 7, 2022
- NCT05553314CollaboratorPhase 4Nov 17, 2021
- NCT05093881Overall official - principal investigatorN/AAug 24, 2021
- NCT04921189CollaboratorPhase 2Jun 4, 2021
- NCT04689152Overall official - principal investigatorPhase 3Mar 2, 2021
- NCT04248621Lead sponsorPhase 4Jan 23, 2020
- NCT04014803CollaboratorPhase 4Jul 8, 2019
- NCT03020628Overall official - principal investigatorPhase 3Oct 1, 2016
- NCT02755701CollaboratorPhase 4Jul 1, 2016
Details
- Founded
- Wonju, KR Jun 1, 1959
- Last known activity
- Aug 13, 2024